Table 4.
A List of Inhaler Products with More Than One Billion U.S. Dollars in 2014 Sales(32)
| Product | Dosage form | Company | 2014 sales ($U.S.) |
|---|---|---|---|
| Seretide/Advair Diskus | DPI | GSK | 7.00 billion |
| Spiriva Handihaler | DPI | Boehringer Ingelheim | 5.07 billion |
| Symbicort | MDI | Astra Zeneca | 2.21 billion |
| Symbicort Turbuhaler | DPI | Astra Zeneca | 1.93 billion |
| Seretide/Advair HFA | MDI | GSK | 1.63 billion |
| Proair | MDI | Teva | 1.45 billion |
| Flovent/Flixotide | MDI | GSK | 1.39 billion |
| Ventolin | MDI | GSK | 1.13 billion |
DPI, dry powder inhaler; MDI, metered dose inhaler.